252 related articles for article (PubMed ID: 26318608)
1. Lacritin and other autophagy associated proteins in ocular surface health.
Karnati R; Talla V; Peterson K; Laurie GW
Exp Eye Res; 2016 Mar; 144():4-13. PubMed ID: 26318608
[TBL] [Abstract][Full Text] [Related]
2. Lacritin and the tear proteome as natural replacement therapy for dry eye.
Karnati R; Laurie DE; Laurie GW
Exp Eye Res; 2013 Dec; 117():39-52. PubMed ID: 23769845
[TBL] [Abstract][Full Text] [Related]
3. Lacritin proteoforms prevent tear film collapse and maintain epithelial homeostasis.
Georgiev GA; Gh MS; Romano J; Dias Teixeira KL; Struble C; Ryan DS; Sia RK; Kitt JP; Harris JM; Hsu KL; Libby A; Odrich MG; Suárez T; McKown RL; Laurie GW
J Biol Chem; 2021; 296():100070. PubMed ID: 33187980
[TBL] [Abstract][Full Text] [Related]
4. The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease.
Dias-Teixeira K; Horton X; McKown R; Romano J; Laurie GW
Adv Exp Med Biol; 2020; 1221():747-757. PubMed ID: 32274735
[TBL] [Abstract][Full Text] [Related]
5. Lacritin rescues stressed epithelia via rapid forkhead box O3 (FOXO3)-associated autophagy that restores metabolism.
Wang N; Zimmerman K; Raab RW; McKown RL; Hutnik CM; Talla V; Tyler MF; Lee JK; Laurie GW
J Biol Chem; 2013 Jun; 288(25):18146-61. PubMed ID: 23640897
[TBL] [Abstract][Full Text] [Related]
6. Lacritin and other new proteins of the lacrimal functional unit.
McKown RL; Wang N; Raab RW; Karnati R; Zhang Y; Williams PB; Laurie GW
Exp Eye Res; 2009 May; 88(5):848-58. PubMed ID: 18840430
[TBL] [Abstract][Full Text] [Related]
7. Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease.
Vijmasi T; Chen FY; Balasubbu S; Gallup M; McKown RL; Laurie GW; McNamara NA
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5401-9. PubMed ID: 25034600
[TBL] [Abstract][Full Text] [Related]
8. Development of a Quantitative Immunoassay for Tear Lacritin Proteoforms.
Justis BM; Coburn CE; Tyler EM; Showalter RS; Dissler BJ; Li M; McNamara NA; Laurie GW; McKown RL
Transl Vis Sci Technol; 2020 Aug; 9(9):13. PubMed ID: 32879769
[TBL] [Abstract][Full Text] [Related]
9. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
10. Corneal autophagy and ocular surface inflammation: A new perspective in dry eye.
Ma S; Yu Z; Feng S; Chen H; Chen H; Lu X
Exp Eye Res; 2019 Jul; 184():126-134. PubMed ID: 31018117
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity.
Velez V F; Romano JA; McKown RL; Green K; Zhang L; Raab RW; Ryan DS; Hutnik CM; Frierson HF; Laurie GW
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2123-32. PubMed ID: 23425695
[TBL] [Abstract][Full Text] [Related]
13. Lacritin Salvages Human Corneal Epithelial Cells from Lipopolysaccharide Induced Cell Death.
Vantaku VR; Gupta G; Rapalli KC; Karnati R
Sci Rep; 2015 Dec; 5():18362. PubMed ID: 26670139
[TBL] [Abstract][Full Text] [Related]
14. Tear lacritin levels by age, sex, and time of day in healthy adults.
Seifert K; Gandia NC; Wilburn JK; Bower KS; Sia RK; Ryan DS; Deaton ML; Still KM; Vassilev VC; Laurie GW; McKown RL
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6610-6. PubMed ID: 22918641
[TBL] [Abstract][Full Text] [Related]
15. Long-term Effects of LASIK on Corneal Innervation and Tear Neuropeptides and the Associations With Dry Eye.
Chao C; Golebiowski B; Zhao X; Chen S; Zhou S; Stapleton F
J Refract Surg; 2016 Aug; 32(8):518-24. PubMed ID: 27505312
[TBL] [Abstract][Full Text] [Related]
16. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
[TBL] [Abstract][Full Text] [Related]
17. Lacritin-induced secretion of tear proteins from cultured monkey lacrimal acinar cells.
Fujii A; Morimoto-Tochigi A; Walkup RD; Shearer TR; Azuma M
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2533-40. PubMed ID: 23482462
[TBL] [Abstract][Full Text] [Related]
18. Tear Osmolarity and Correlation With Ocular Surface Parameters in Patients With Dry Eye.
Mathews PM; Karakus S; Agrawal D; Hindman HB; Ramulu PY; Akpek EK
Cornea; 2017 Nov; 36(11):1352-1357. PubMed ID: 28872518
[TBL] [Abstract][Full Text] [Related]
19. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease.
Bensaoula T; Shibuya H; Katz ML; Smith JE; Johnson GS; John SK; Milam AH
Ophthalmology; 2000 Sep; 107(9):1746-53. PubMed ID: 10964839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
